Informatie:
Fout:
ID
34320
Beschrijving
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT01590641
Link
https://clinicaltrials.gov/show/NCT01590641
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis B NCT01590641
Eligibility Hepatitis B NCT01590641
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B NCT01590641
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
chronic hbv infection ≥ 6 months
boolean
ID.2
Item
hbsag ≥ 250 iu/ml
boolean
ID.3
Item
hbv treatment naïve
boolean
ID.4
Item
absence of extensive bridging fibrosis (metavir 3 or greater) or cirrhosis
boolean
ID.5
Item
creatinine clearance ≥ 70 ml/min
boolean
ID.6
Item
co-infection with hepatitis c virus (hcv), hepatitis d virus (hdv), or hiv
boolean
ID.7
Item
history of gilberts disease
boolean
ID.8
Item
laboratory parameters not within defined thresholds for leukopenia, neutropenia, anemia, thrombocytopenia, thyroid-stimulating hormone (tsh), or other evidence of hepatic decompensation
boolean
ID.9
Item
diagnosis of autoimmune disease, poorly controlled diabetes mellitus, significant psychiatric illness, severe chronic obstructive pulmonary disease(copd), malignancy, hemoglobinopathy, retinal disease, or patients who are immunosuppressed
boolean
ID.10
Item
evidence of hepatocellular carcinoma
boolean